SpaceOAR® hydrogel is a “game changing” technology redefining the outcomes of prostate radiotherapy for men with prostate cancer.

The hydrogel technology allows for east insertion, natural absorption and the creation of space between the prostate and rectum.

Over 5000 Australian men so far have benefited from having SpaceOAR® inserted before their radiotheraphy.

By separating the prostate from the anterior rectal wall, SpaceOAR® creates an average 1cm of space to enhance your prostate cancer treatment while reducing your risk of side effects.

SpaceOAR® hydrogel is clinically proven to minimise urinary, sexual, bowel side effects and protect quality of life for prostate cancer patients undergoing radiation therapy.

SpaceOAR® hydrogel in an inert, two-part liquid solution that is inserted through the perineum into the rectal space (between the anterior rectal wall and the prostate). As the liquid is injected it mixes to create a hydrogel that will keep its shape for 3 months and be totally resorbed after 6 months.

Studies have shown this space allows for the reduction of rectal V70 by greater than 25% and thus a reduction of Grade 2 toxicities – the most common side effect of radiotherapy.